Clinical Approach to Wheezing
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of wheezing
Wheezing is one of the most common respiratory symptoms encountered in primary care, affecting approximately 25-30% of infants and young children at some point, and persisting as a chronic symptom in 5-10% of the adult population. In the United States alone, wheezing-related complaints account for millions of outpatient visits annually, with asthma—the leading cause of wheezing—affecting over 25 million Americans. The economic burden is substantial, with direct and indirect costs exceeding $80 billion per year. Beyond asthma, wheezing serves as a critical clinical indicator of airway obstruction that may signal conditions ranging from benign viral infections to life-threatening anaphylaxis or foreign body aspiration.
Definition
Wheezing is a continuous, high-pitched, musical sound produced by turbulent airflow through narrowed or compressed airways. It is most commonly heard during expiration but may occur during inspiration or both phases of respiration depending on the location and severity of obstruction. Wheezing indicates that airway diameter has been reduced to the point where airflow becomes turbulent rather than laminar.
Key Epidemiology
- Asthma prevalence: 8-10% of adults, 10-12% of children worldwide
- Chronic obstructive pulmonary disease: Affects approximately 380 million people globally; third leading cause of death worldwide
- Acute bronchitis: Accounts for approximately 10 million physician visits annually in the United States
- Wheezing in smokers: Present in up to 40% of current smokers
Classification by Duration
| Category | Duration | Common Causes | Clinical Significance |
|---|---|---|---|
| Acute | Less than 2 weeks | Viral respiratory infections, acute asthma exacerbation, anaphylaxis, foreign body aspiration, acute heart failure | Requires immediate assessment for life-threatening causes; most cases are self-limiting viral infections |
| Subacute | 2 to 8 weeks | Post-infectious bronchial hyperreactivity, undiagnosed asthma, resolving pneumonia, pertussis | Often represents prolonged inflammation; consider bronchial hyperreactivity and occult asthma |
| Chronic | Greater than 8 weeks | Asthma, chronic obstructive pulmonary disease, bronchiectasis, cardiac disease, endobronchial lesions | Requires systematic workup; smoking history and spirometry are essential |
Classification by Character
Polyphonic Wheezing
Description: Multiple musical notes of varying pitch occurring simultaneously
Mechanism: Diffuse airway narrowing affecting multiple bronchi of different calibers
Clinical implication: Suggests generalized airway disease such as asthma or chronic obstructive pulmonary disease
Monophonic Wheezing
Description: Single constant pitch, often louder and more localized
Mechanism: Fixed obstruction in a single large airway
Clinical implication: Suggests focal obstruction—consider foreign body, tumor, or extrinsic compression
Expiratory Wheezing
Description: Wheezing heard predominantly or exclusively during exhalation
Mechanism: Intrathoracic airway narrowing worsens during expiration due to positive pleural pressure
Clinical implication: Classic for asthma and chronic obstructive pulmonary disease; indicates lower airway obstruction
Inspiratory Wheezing (Stridor)
Description: Wheezing or high-pitched sound heard predominantly during inhalation
Mechanism: Extrathoracic airway obstruction worsens during inspiration due to negative intraluminal pressure
Clinical implication: Suggests upper airway obstruction—laryngeal edema, vocal cord dysfunction, or tracheal lesion
Classification by Pattern and Timing
| Pattern | Description | Suggests |
|---|---|---|
| Episodic with triggers | Wheezing occurs with specific exposures (allergens, exercise, cold air) and resolves between episodes | Asthma, allergic bronchospasm |
| Nocturnal predominance | Wheezing worse at night or early morning, often disrupting sleep | Asthma (circadian variation), gastroesophageal reflux disease, heart failure |
| Persistent and progressive | Continuous wheezing that worsens over weeks to months | Chronic obstructive pulmonary disease, endobronchial tumor, progressive heart failure |
| Seasonal variation | Wheezing correlates with pollen seasons or weather changes | Allergic asthma, seasonal allergic rhinitis with asthma |
| Postprandial | Wheezing occurring after meals, especially when lying down | Gastroesophageal reflux disease with aspiration, aspiration due to swallowing dysfunction |
| Exertional | Wheezing triggered by physical activity | Exercise-induced bronchoconstriction, cardiac asthma, deconditioning |
| Sudden onset with choking | Abrupt wheezing following eating or playing with small objects | Foreign body aspiration—requires urgent evaluation |
Key Concept: “All That Wheezes Is Not Asthma”
While asthma and chronic obstructive pulmonary disease account for the majority of wheezing in adults, clinicians must remain vigilant for alternative diagnoses. The differential includes cardiac causes (heart failure—”cardiac asthma”), upper airway obstruction (vocal cord dysfunction, laryngeal tumors), and focal lesions (foreign body, endobronchial tumors). A new-onset monophonic wheeze in a smoker over age 40 should raise concern for malignancy until proven otherwise.
Impact on Quality of Life
| Domain | Impact |
|---|---|
| Sleep | Nocturnal wheezing causes sleep fragmentation, daytime fatigue, and impaired concentration |
| Physical activity | Exercise limitation leads to deconditioning, weight gain, and reduced cardiovascular fitness |
| Work productivity | Asthma alone accounts for nearly 15 million missed workdays annually in the United States |
| Psychological | Anxiety, depression, and fear of attacks are common in patients with chronic wheezing disorders |
| Social | Avoidance of triggers may limit social activities, travel, and pet ownership |
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of wheezing
Wheezing occurs when airflow through the bronchial tree becomes turbulent due to narrowing of the airway lumen. According to principles of fluid dynamics, laminar (smooth, silent) airflow transitions to turbulent (noisy) flow when the velocity of air increases or when the diameter of the conducting tube decreases. The musical quality of wheezing results from oscillation of the airway walls as air is forced through the narrowed segment, similar to how a reed instrument produces sound. Understanding the mechanisms of airway narrowing is essential for accurate diagnosis and targeted treatment.
Four Mechanisms of Airway Narrowing
| Mechanism | Pathophysiology | Examples | Treatment Principle |
|---|---|---|---|
| Bronchospasm | Contraction of bronchial smooth muscle mediated by parasympathetic activation, histamine, leukotrienes, or direct irritant stimulation | Asthma, anaphylaxis, irritant exposure | Bronchodilators (beta-2 agonists, anticholinergics) |
| Mucosal edema | Inflammatory swelling of the airway mucosa due to vascular leak, cellular infiltration, and cytokine release | Asthma, viral bronchitis, allergic reactions | Anti-inflammatory agents (corticosteroids) |
| Mucus hypersecretion | Excessive production of mucus by goblet cells and submucosal glands, often with impaired mucociliary clearance | Chronic obstructive pulmonary disease, chronic bronchitis, bronchiectasis | Mucolytics, chest physiotherapy, hydration |
| Structural narrowing | Fixed reduction in airway caliber due to remodeling, external compression, or intraluminal mass | Airway remodeling in chronic asthma, tumors, foreign body, goiter | Address underlying cause (surgery, radiation, removal) |
The Physics of Wheeze Production
Key Principle: Wheezing requires a critical balance between airway narrowing and airflow velocity. If the airway becomes completely occluded or airflow is too slow, no wheeze is produced. This explains the dangerous “silent chest” in severe asthma—airways are so severely narrowed that airflow is insufficient to generate wheezing.
| Physical Principle | Explanation | Clinical Relevance |
|---|---|---|
| Bernoulli effect | As airflow velocity increases through a narrowed segment, pressure decreases, causing further airway collapse | Explains dynamic airway collapse during forced expiration |
| Flutter mechanism | Airway walls oscillate between open and nearly closed states as pressure fluctuates | Produces the musical quality of wheezing |
| Critical velocity threshold | Minimum airflow velocity required to produce turbulence and audible wheeze | Explains why severe obstruction may be silent |
Why Expiratory Wheezing Is More Common
During Expiration
Pleural pressure: Becomes positive
Effect on intrathoracic airways: External compression narrows airways
Result: Airways that are already narrowed by disease become even more constricted, producing wheezing
During Inspiration
Pleural pressure: Becomes negative
Effect on intrathoracic airways: Negative pressure helps hold airways open
Result: Intrathoracic obstruction is partially relieved; inspiratory wheezing suggests extrathoracic obstruction
Pathophysiology by Anatomical Location
| Location | Phase of Respiration Affected | Mechanism | Examples |
|---|---|---|---|
| Extrathoracic (larynx, upper trachea) | Inspiratory stridor predominates | Negative intraluminal pressure during inspiration causes airway collapse | Vocal cord dysfunction, laryngeal edema, epiglottitis, tracheal tumor |
| Intrathoracic—large airways (lower trachea, main bronchi) | Both inspiratory and expiratory or predominantly expiratory | Fixed obstruction or dynamic compression during expiration | Tracheomalacia, endobronchial tumor, foreign body in main bronchus |
| Intrathoracic—small airways (bronchioles) | Expiratory wheezing predominates | Bronchospasm, mucosal edema, and mucus plugging; positive pleural pressure compresses small airways during expiration | Asthma, chronic obstructive pulmonary disease, bronchiolitis |
How Specific Conditions Cause Wheezing
| Condition | Primary Mechanism | Contributing Factors | Treatment Implication |
|---|---|---|---|
| Asthma | Bronchospasm due to airway hyperreactivity; eosinophilic inflammation causes mucosal edema | Mucus hypersecretion, airway remodeling with chronicity | Inhaled corticosteroids for inflammation; bronchodilators for acute symptoms |
| Chronic obstructive pulmonary disease | Loss of elastic recoil leads to dynamic airway collapse; chronic inflammation and mucus hypersecretion | Emphysematous destruction, chronic bronchitis component | Long-acting bronchodilators; smoking cessation is essential |
| Heart failure (“cardiac asthma”) | Pulmonary venous congestion causes bronchial wall edema and peribronchial cuffing | Reflex bronchospasm due to J-receptor stimulation | Diuretics and heart failure management rather than bronchodilators |
| Anaphylaxis | Massive mast cell degranulation releases histamine and leukotrienes causing bronchospasm and mucosal edema | Upper airway edema may cause stridor | Epinephrine is first-line; bronchodilators are adjunctive |
| Vocal cord dysfunction | Paradoxical adduction of vocal cords during inspiration causes extrathoracic obstruction | Often triggered by stress, exercise, or irritants; may coexist with asthma | Speech therapy and behavioral techniques; does not respond to bronchodilators |
| Foreign body aspiration | Physical obstruction of airway by aspirated material | Ball-valve effect may cause hyperinflation distal to obstruction | Bronchoscopic removal |
| Gastroesophageal reflux disease | Microaspiration of gastric contents irritates airways; vagal reflex bronchospasm | May trigger nocturnal symptoms | Proton pump inhibitors; lifestyle modifications |
Key Inflammatory Pathways in Asthma
Type 2 (Eosinophilic) Inflammation
Key cells: Eosinophils, mast cells, T-helper 2 lymphocytes
Mediators: Interleukin-4, interleukin-5, interleukin-13, immunoglobulin E
Clinical features: Allergic triggers, elevated blood eosinophils, responds well to corticosteroids
Non-Type 2 (Neutrophilic) Inflammation
Key cells: Neutrophils
Triggers: Infections, pollution, smoking
Clinical features: Often more severe, less responsive to corticosteroids
Airway Remodeling
Changes: Subepithelial fibrosis, smooth muscle hypertrophy, goblet cell hyperplasia
Result: Fixed airway narrowing that persists even when inflammation is controlled
Prevention: Early anti-inflammatory treatment
Often Overlooked Mechanism: Cardiac Asthma
Heart failure can present with wheezing that closely mimics asthma, particularly in elderly patients. The mechanism involves pulmonary venous congestion causing peribronchial edema, which narrows airways and triggers reflex bronchospasm via vagal C-fiber activation. Clues include orthopnea, paroxysmal nocturnal dyspnea, elevated jugular venous pressure, and peripheral edema. Treating with bronchodilators alone will not address the underlying problem—these patients need diuresis and optimization of cardiac function. Always consider cardiac asthma in elderly patients with new-onset wheezing, especially if they have risk factors for heart disease.
The “Silent Chest” — A Critical Warning
In severe asthma exacerbations, airflow may become so limited that wheezing disappears—this is an ominous sign indicating impending respiratory failure. The absence of wheezing in a patient with severe respiratory distress should prompt immediate concern, not reassurance. Look for other signs of severity: inability to speak in full sentences, use of accessory muscles, paradoxical breathing, altered mental status, and cyanosis. Immediate intervention with bronchodilators, systemic corticosteroids, and preparation for possible intubation is required.
3. History Taking
A comprehensive approach to eliciting the wheezing history
Red Flags — Require Urgent Evaluation
- Sudden onset with choking episode — Foreign body aspiration
- Associated facial or lip swelling — Anaphylaxis
- Stridor with drooling — Upper airway obstruction, epiglottitis
- Inability to speak in full sentences — Severe bronchospasm, impending respiratory failure
- Altered mental status — Hypoxia, hypercapnia, impending arrest
- Cyanosis — Severe hypoxemia requiring immediate intervention
- Silent chest in distressed patient — Critical airway obstruction
- New-onset monophonic wheeze in smoker over age 40 — Possible malignancy
- Hemoptysis with wheezing — Malignancy, pulmonary embolism, vasculitis
- Orthopnea and paroxysmal nocturnal dyspnea — Heart failure
Systematic History: The “WHEEZE” Approach
Use the mnemonic “WHEEZE” to ensure comprehensive history taking:
- W — When and What triggered it? Onset, duration, triggers (allergens, exercise, cold air, infections, irritants)
- H — How does it sound and where? Character (musical, harsh), location (diffuse, localized), phase (expiratory, inspiratory, both)
- E — Episodes or Everyday? Pattern (intermittent versus persistent), frequency, seasonality, nocturnal symptoms
- E — Extra symptoms? Associated symptoms (cough, dyspnea, chest tightness, sputum, fever, weight loss, orthopnea)
- Z — Zoning in on risk factors Personal and family history of atopy, smoking, occupational exposures, medications
- E — Effect on life and Existing treatments? Impact on sleep, work, exercise; response to bronchodilators, prior treatments tried
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Asthma | Episodic symptoms, nocturnal worsening, atopic history, trigger-related | “Do you have allergies, eczema, or hay fever? Does cold air, exercise, or dust make it worse?” |
| Chronic obstructive pulmonary disease | Persistent symptoms, productive cough, smoking history, progressive dyspnea | “How many pack-years have you smoked? Do you cough up sputum most days?” |
| Heart failure | Orthopnea, paroxysmal nocturnal dyspnea, leg swelling, exertional limitation | “How many pillows do you sleep on? Do you wake up at night gasping for air? Are your ankles swollen?” |
| Anaphylaxis | Rapid onset, exposure to allergen, urticaria, angioedema, hypotension | “Did this start suddenly after eating, being stung, or taking a new medication? Any hives or swelling?” |
| Foreign body aspiration | Sudden onset, choking episode, unilateral wheeze, history of eating or playing with small objects | “Were you eating or had anything in your mouth when this started? Did you choke or cough suddenly?” |
| Vocal cord dysfunction | Inspiratory stridor, throat tightness, poor response to bronchodilators, emotional triggers | “Do you feel the tightness more in your throat than your chest? Does stress trigger episodes?” |
| Gastroesophageal reflux disease | Postprandial worsening, nocturnal symptoms, heartburn, regurgitation | “Is the wheezing worse after meals or when lying down? Do you have heartburn or acid taste?” |
| Occupational asthma | Symptoms improve on weekends or holidays, exposure to workplace irritants | “Does your breathing improve when you’re away from work for several days? What chemicals or dusts are you exposed to?” |
| Bronchiectasis | Chronic productive cough, recurrent infections, large volume purulent sputum | “Do you cough up large amounts of sputum daily? Have you had repeated chest infections?” |
| Endobronchial tumor | Monophonic wheeze, hemoptysis, weight loss, smoking history, progressive symptoms | “Have you coughed up any blood? Have you lost weight without trying?” |
Characterizing the Wheeze
| Question | Why It Matters | What the Answer Suggests |
|---|---|---|
| “Can you hear the wheeze yourself, or only the doctor?” | Audible wheeze suggests more severe obstruction | Patient-audible wheeze often indicates significant airway narrowing |
| “Is it the same pitch always, or does it vary?” | Distinguishes monophonic from polyphonic | Fixed pitch suggests focal obstruction; variable pitch suggests diffuse disease |
| “Is it worse breathing in or out?” | Localizes the obstruction | Inspiratory suggests upper airway; expiratory suggests lower airway |
| “Does a blue inhaler help?” | Response to bronchodilator is diagnostic | Good response supports asthma; poor response suggests fixed obstruction or non-bronchospastic cause |
Medication and Social History
Medications That Can Cause or Worsen Wheezing
- Beta-blockers (including eye drops) — Block beta-2 receptors causing bronchospasm; even topical timolol can precipitate severe asthma
- Nonsteroidal anti-inflammatory drugs — Aspirin-exacerbated respiratory disease in susceptible patients
- Angiotensin-converting enzyme inhibitors — Cause cough and may exacerbate underlying airways disease
- Cholinergic agents — Increase bronchial secretions and tone
- Adenosine — Can trigger bronchospasm during cardiac testing
- Contrast media — Anaphylactoid reactions
- Antibiotics (especially penicillins) — Allergic reactions
Social and Occupational History
- Smoking: Pack-years calculation essential; includes secondhand smoke exposure and vaping
- Occupation: Bakers (flour), painters (isocyanates), healthcare workers (latex), farmers (organic dusts), cleaners (chemicals)
- Home environment: Pets, carpeting, mold, dust, heating systems, cockroaches
- Hobbies: Woodworking, painting, gardening (pollens)
- Travel: Exposure to tuberculosis or parasitic infections
- Recreational drugs: Inhaled cocaine, marijuana can cause bronchospasm
Personal and Family Atopic History
The Atopic Triad
Asthma, allergic rhinitis, and atopic dermatitis (eczema) frequently coexist and have shared genetic susceptibility. A personal or family history of any of these conditions significantly increases the likelihood that wheezing is due to asthma. Ask specifically about:
- Childhood eczema or current skin problems
- Seasonal or perennial nasal symptoms (sneezing, rhinorrhea, congestion)
- Food allergies or anaphylaxis history
- Family members with asthma, hay fever, or eczema
Assessing Disease Impact
| Domain | Questions to Ask | Clinical Significance |
|---|---|---|
| Sleep | “How many nights per week do you wake up with wheezing or breathlessness?” | Nocturnal symptoms indicate poor asthma control; more than 2 nights per month suggests inadequately controlled disease |
| Activity limitation | “What activities can you no longer do because of your breathing?” | Progressive limitation suggests worsening obstruction or deconditioning |
| Reliever use | “How often do you use your rescue inhaler?” | More than 2 times per week (excluding pre-exercise) indicates poor control |
| Exacerbations | “How many times in the past year have you needed steroids or gone to hospital for your breathing?” | Frequent exacerbations indicate high-risk disease requiring step-up therapy |
| Work and school | “How many days have you missed work or school due to breathing problems?” | Quantifies socioeconomic impact; helps assess treatment adequacy |
4. Physical Examination
A systematic head-to-toe approach for wheezing
Systematic Framework: Use the “General to Specific” approach—begin with overall appearance and vital signs, then focus on the respiratory system while not neglecting cardiac, upper airway, and systemic examination. Remember that the examination may be entirely normal between episodes in patients with intermittent asthma.
General Inspection
- Level of distress: Calm and comfortable versus anxious, diaphoretic, or exhausted (suggests severe obstruction)
- Position: Sitting upright, leaning forward with hands on knees (tripod position) suggests severe respiratory distress
- Speech: Able to speak in full sentences (mild), phrases only (moderate), words only (severe), or unable to speak (critical)
- Color: Cyanosis (central or peripheral) indicates severe hypoxemia; pallor may suggest anemia
- Audible sounds: Wheeze audible without stethoscope indicates significant obstruction; stridor suggests upper airway involvement
- Body habitus: Obesity (associated with asthma, heart failure, obstructive sleep apnea), cachexia (malignancy, severe chronic obstructive pulmonary disease)
- Accessory muscle use: Sternocleidomastoid, scalene, and intercostal muscle recruitment indicates increased work of breathing
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Respiratory rate | Tachypnea (greater than 20 breaths per minute in adults) | Indicates increased ventilatory demand; very high rates suggest impending fatigue |
| Oxygen saturation | Less than 92% on room air is concerning; less than 90% requires urgent intervention | May be preserved until late in asthma due to hyperventilation; low saturation is a red flag |
| Heart rate | Tachycardia (greater than 100 beats per minute) | May reflect hypoxemia, anxiety, or beta-agonist use; pulsus paradoxus greater than 12 mmHg suggests severe obstruction |
| Blood pressure | Hypertension or hypotension | Hypotension in wheezing patient raises concern for anaphylaxis or tension pneumothorax |
| Temperature | Fever | Suggests infectious trigger (viral infection, pneumonia); high fever with stridor may indicate epiglottitis |
| Peak expiratory flow | Less than 50% of predicted or personal best | Objective measure of airflow obstruction; less than 25% indicates life-threatening attack |
Pulsus Paradoxus: A Valuable Bedside Sign
Pulsus paradoxus is an exaggerated fall in systolic blood pressure (greater than 10-12 mmHg) during inspiration. In severe asthma, large negative intrathoracic pressures during inspiration increase venous return to the right heart and impede left ventricular filling, causing the blood pressure to drop. Measure by inflating the blood pressure cuff above systolic pressure, then slowly deflating until you first hear Korotkoff sounds (initially only during expiration). Continue deflating until sounds are heard throughout the respiratory cycle. The difference between these two points is the pulsus paradoxus. A value greater than 12 mmHg suggests severe obstruction.
Head and Neck Examination
Upper Airway
Nasal passages: Mucosal edema, polyps, septal deviation, purulent discharge (suggests rhinosinusitis)
Oropharynx: Cobblestoning of posterior pharynx (post-nasal drip), tonsillar hypertrophy, oropharyngeal edema (anaphylaxis)
Voice: Hoarseness may indicate laryngeal involvement, vocal cord dysfunction, or recurrent laryngeal nerve compression
Neck
Trachea: Midline position; deviation suggests tension pneumothorax, large effusion, or mass
Lymph nodes: Cervical lymphadenopathy (infection, malignancy)
Thyroid: Goiter causing tracheal compression can produce wheeze or stridor
Jugular venous pressure: Elevation suggests right heart failure or cor pulmonale
Respiratory Examination
Inspection
- Chest shape: Barrel chest (hyperinflation in chronic obstructive pulmonary disease or chronic severe asthma), kyphoscoliosis (restrictive lung disease)
- Breathing pattern: Prolonged expiratory phase (obstruction), pursed-lip breathing (chronic obstructive pulmonary disease), paradoxical abdominal movement (diaphragm fatigue)
- Accessory muscle use: Visible contraction of sternocleidomastoids, scalenes, and intercostals indicates severe obstruction
- Intercostal recession: Indrawing of intercostal spaces during inspiration suggests severe obstruction
- Symmetry: Asymmetric expansion may indicate unilateral pathology (pneumothorax, effusion, collapse, foreign body)
Palpation
- Tracheal position: Midline or deviated
- Chest expansion: Reduced bilaterally in hyperinflation; asymmetric in unilateral disease
- Tactile fremitus: Decreased over effusion or pneumothorax; increased over consolidation
- Subcutaneous emphysema: Crepitus suggests pneumothorax or pneumomediastinum
Percussion
- Hyperresonance: Suggests hyperinflation (asthma, chronic obstructive pulmonary disease) or pneumothorax
- Dullness: Indicates consolidation, effusion, or mass
- Symmetry: Compare both hemithoraces systematically
Auscultation
| Finding | Description | Associated Conditions |
|---|---|---|
| Polyphonic expiratory wheeze | Multiple musical notes of varying pitch, bilateral, predominantly expiratory | Asthma, chronic obstructive pulmonary disease, bronchiolitis |
| Monophonic wheeze | Single fixed pitch, may be localized to one area | Foreign body, endobronchial tumor, mucus plug, external compression |
| Inspiratory stridor | High-pitched sound during inspiration, often loudest over the neck | Laryngeal edema, epiglottitis, vocal cord dysfunction, tracheal stenosis |
| Biphasic wheeze or stridor | Present during both inspiration and expiration | Fixed upper airway obstruction, severe lower airway obstruction |
| Silent chest | Markedly reduced or absent breath sounds despite respiratory effort | Critical asthma (insufficient airflow to generate wheeze), pneumothorax, massive effusion |
| Crackles with wheeze | Fine or coarse crackles in addition to wheezing | Heart failure (fine, bibasilar), bronchiectasis (coarse), pneumonia |
| Prolonged expiratory phase | Expiration takes longer than inspiration (normal ratio approximately 1:2, reversed in obstruction) | Obstructive airways disease (asthma, chronic obstructive pulmonary disease) |
| Decreased breath sounds | Reduced air entry, may be focal or diffuse | Hyperinflation, effusion, pneumothorax, consolidation, obesity |
Cardiovascular Examination
| Finding | Technique | Clinical Significance |
|---|---|---|
| Jugular venous pressure | Assess with patient at 45 degrees | Elevation suggests right heart failure, cor pulmonale, or fluid overload |
| Apex beat | Palpate in left lateral position if not felt initially | Displaced laterally in cardiomegaly; difficult to feel in hyperinflation |
| Heart sounds | Listen in all four areas | S3 gallop suggests heart failure; loud P2 suggests pulmonary hypertension |
| Murmurs | Characterize timing, location, radiation | Mitral stenosis can cause “cardiac asthma”; tricuspid regurgitation in cor pulmonale |
| Peripheral edema | Check ankles, sacrum in bedridden patients | Bilateral edema suggests heart failure; unilateral raises concern for deep vein thrombosis |
Abdominal Examination
- Hepatomegaly: Tender, pulsatile liver suggests right heart failure and hepatic congestion
- Ascites: May accompany severe heart failure; shifting dullness and fluid wave
- Hepatojugular reflux: Sustained elevation of jugular venous pressure with abdominal pressure suggests right heart failure
- Obesity: Central obesity associated with asthma, sleep apnea, and reduced functional residual capacity
Extremities
Clubbing
Description: Loss of nail bed angle, increased nail curvature
Significance: NOT expected in asthma or chronic obstructive pulmonary disease—if present, consider lung cancer, bronchiectasis, interstitial lung disease, or cyanotic heart disease
Cyanosis
Description: Bluish discoloration of nail beds and lips
Significance: Indicates significant hypoxemia (oxygen saturation typically less than 85%); a late and ominous sign
Peripheral Edema
Description: Pitting edema of ankles and legs
Significance: Suggests right heart failure, cor pulmonale (from chronic hypoxemia), or fluid overload
Skin Examination
- Eczema: Flexural dermatitis suggests atopic diathesis, supporting asthma diagnosis
- Urticaria: Raised, pruritic wheals suggest allergic reaction or anaphylaxis
- Angioedema: Swelling of lips, tongue, or periorbital area—indicates anaphylaxis or hereditary angioedema
- Nicotine staining: Yellow-brown staining of fingers suggests ongoing smoking
Expected Findings by Etiology
| Condition | General Appearance | Respiratory Findings | Other Key Findings |
|---|---|---|---|
| Asthma (mild-moderate) | Comfortable at rest, speaks in sentences | Expiratory wheeze, prolonged expiration, may be normal between attacks | May have allergic shiners, nasal polyps, eczema |
| Asthma (severe) | Distressed, tripod position, speaks in words | Loud wheeze or silent chest, accessory muscle use, poor air entry | Tachycardia, pulsus paradoxus, cyanosis in critical cases |
| Chronic obstructive pulmonary disease | Barrel chest, pursed-lip breathing, thin | Reduced breath sounds, scattered wheeze and crackles, hyperresonant | Nicotine staining, clubbing absent, may have cor pulmonale signs |
| Heart failure | Orthopneic, may be dyspneic at rest | Bibasilar crackles, wheeze (“cardiac asthma”), reduced air entry at bases | Elevated jugular venous pressure, S3 gallop, peripheral edema, hepatomegaly |
| Anaphylaxis | Anxious, may be hypotensive, distressed | Diffuse wheeze, possible stridor if laryngeal edema | Urticaria, angioedema, flushing, hypotension, tachycardia |
| Foreign body aspiration | May appear well or distressed depending on degree of obstruction | Unilateral wheeze, asymmetric breath sounds, localized hyperresonance | History of choking, may have normal examination if partial obstruction |
| Vocal cord dysfunction | Often anxious, throat clutching | Inspiratory stridor, cervical wheeze, normal lung examination | Symptoms often stop abruptly; no response to bronchodilators |
Important Teaching Point
Normal examination is common in intermittent asthma! Many patients with well-controlled or intermittent asthma will have completely normal physical examination findings between exacerbations. The absence of wheezing does not exclude asthma—the diagnosis relies on the pattern of symptoms, triggers, response to bronchodilators, and objective testing (spirometry with bronchodilator reversibility or bronchial challenge testing). Never dismiss a patient’s symptoms simply because the examination is normal; proceed with appropriate investigations.
5. Differential Diagnosis
Systematic approach organized by probability and clinical features
Acute Wheezing (Duration: Less Than 2 Weeks)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (approximately 75%) | Acute asthma exacerbation | Known asthmatic, trigger exposure, episodic pattern, responds to bronchodilators | Silent chest, inability to speak, altered consciousness |
| Viral upper respiratory infection with reactive airways | Preceding coryza, low-grade fever, cough, self-limiting | High fever, productive purulent sputum, hypoxia | |
| Acute exacerbation of chronic obstructive pulmonary disease | Smoking history, baseline dyspnea, increased sputum volume or purulence | Severe hypoxia, confusion, respiratory acidosis | |
| Acute bronchitis | Cough predominant, viral prodrome, chest discomfort, usually self-limiting | Persistent high fever, focal consolidation signs | |
| LESS COMMON (approximately 20%) | Pneumonia with bronchospasm | Fever, productive cough, focal crackles, may have pleuritic chest pain | Sepsis, multilobar involvement, cavitation |
| Acute heart failure (pulmonary edema) | Orthopnea, paroxysmal nocturnal dyspnea, peripheral edema, cardiac history | Hypotension, cardiogenic shock, acute myocardial infarction | |
| Allergic reaction (without anaphylaxis) | Exposure to allergen, urticaria, mild angioedema, responds to antihistamines | Progression to anaphylaxis (hypotension, stridor) | |
| UNCOMMON BUT SERIOUS (approximately 5%) | Anaphylaxis | Rapid onset after exposure, urticaria, angioedema, hypotension, multisystem | Airway compromise, cardiovascular collapse |
| Foreign body aspiration | Sudden onset with choking, unilateral wheeze, history of eating or playing with small objects | Complete airway obstruction, respiratory arrest | |
| Pulmonary embolism | Sudden dyspnea, pleuritic chest pain, risk factors (immobility, malignancy, recent surgery) | Hemodynamic instability, massive pulmonary embolism | |
| Pneumothorax | Sudden onset, unilateral decreased breath sounds, pleuritic pain | Tension pneumothorax (tracheal deviation, hypotension) |
Chronic Wheezing (Duration: Greater Than 8 Weeks)
Step-by-Step Approach to Chronic Wheezing:
- Step 1: Rule out the obvious — Is the patient a smoker? Taking beta-blockers or angiotensin-converting enzyme inhibitors? Has asthma ever been formally diagnosed?
- Step 2: Consider the “Big Three” causes of chronic wheezing — Asthma, chronic obstructive pulmonary disease, and heart failure account for the vast majority of cases
- Step 3: If initial workup is negative, investigate for less common causes including vocal cord dysfunction, bronchiectasis, and endobronchial lesions
- Step 4: Remember that multiple conditions may coexist — asthma-chronic obstructive pulmonary disease overlap, heart failure with chronic obstructive pulmonary disease
| Probability | Condition | Approximate Frequency | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Asthma | 30-40% | Variable symptoms, nocturnal worsening, triggers, atopic history, reversible obstruction on spirometry, responds to inhaled corticosteroids |
| Chronic obstructive pulmonary disease | 25-35% | Smoking history (greater than 10 pack-years), persistent symptoms, progressive dyspnea, fixed obstruction on spirometry, incomplete bronchodilator response | |
| Heart failure | 10-15% | Orthopnea, paroxysmal nocturnal dyspnea, peripheral edema, elevated brain natriuretic peptide, cardiomegaly, responds to diuretics | |
| LESS COMMON | Asthma-chronic obstructive pulmonary disease overlap | 5-10% | Features of both conditions, significant smoking history plus atopy, variable but incompletely reversible obstruction |
| Gastroesophageal reflux disease | 5-10% | Postprandial worsening, nocturnal symptoms, heartburn, regurgitation, may coexist with asthma | |
| Vocal cord dysfunction | 3-5% | Inspiratory stridor, throat tightness, anxiety triggers, poor bronchodilator response, flattened inspiratory loop on spirometry | |
| Bronchiectasis | 3-5% | Chronic productive cough with large volume purulent sputum, recurrent infections, clubbing may be present | |
| UNCOMMON BUT IMPORTANT | Endobronchial tumor (primary or metastatic) | 1-3% | Monophonic wheeze, hemoptysis, weight loss, smoking history, progressive symptoms |
| Tracheal stenosis | Less than 1% | History of prolonged intubation, fixed stridor, biphasic wheeze, does not respond to bronchodilators | |
| Carcinoid tumor | Less than 1% | Recurrent pneumonia in same location, flushing, diarrhea (carcinoid syndrome) | |
| Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) | Rare | Asthma with eosinophilia, neuropathy, skin lesions, sinusitis, systemic vasculitis features | |
| Allergic bronchopulmonary aspergillosis | Rare | Poorly controlled asthma, central bronchiectasis, elevated immunoglobulin E, eosinophilia, positive Aspergillus serology |
Anatomical Approach to Wheezing
Upper Airway (Extrathoracic)
Vocal cord dysfunction
Laryngeal edema or tumor
Tracheal stenosis
Goiter with tracheal compression
Epiglottitis
Laryngomalacia
Large Airways (Central)
Endobronchial tumor
Foreign body aspiration
Tracheobronchomalacia
Extrinsic compression (lymph nodes, aortic aneurysm)
Mucus plugging
Endobronchial tuberculosis
Small Airways (Peripheral)
Asthma
Chronic obstructive pulmonary disease
Bronchiolitis
Bronchiectasis
Cystic fibrosis
Hypersensitivity pneumonitis
Extra-Pulmonary
Heart failure (cardiac asthma)
Gastroesophageal reflux disease
Pulmonary embolism
Carcinoid syndrome
Anaphylaxis
Drug-induced bronchospasm
Drug-Induced Wheezing and Bronchospasm
| Drug or Drug Class | Mechanism | Characteristics | Management |
|---|---|---|---|
| Beta-blockers (oral and topical ophthalmic) | Block beta-2 receptors on bronchial smooth muscle, preventing bronchodilation | Can precipitate severe bronchospasm in asthmatics; even cardioselective agents not completely safe; timolol eye drops are a common culprit | Avoid in asthma; use cardioselective agents with caution in chronic obstructive pulmonary disease if essential; consider alternative glaucoma treatments |
| Nonsteroidal anti-inflammatory drugs and aspirin | Inhibition of cyclooxygenase-1 shifts arachidonic acid metabolism toward leukotriene pathway | Aspirin-exacerbated respiratory disease: asthma, nasal polyps, aspirin sensitivity; occurs 30 minutes to 3 hours after ingestion | Strict avoidance of all cyclooxygenase-1 inhibitors; leukotriene receptor antagonists may help; aspirin desensitization in specialized centers |
| Angiotensin-converting enzyme inhibitors | Bradykinin accumulation causes airway irritation and cough; may exacerbate underlying airway hyperreactivity | Primarily causes cough but can worsen wheezing in patients with underlying airways disease | Switch to angiotensin receptor blocker; cough may take 1-4 weeks to resolve |
| Cholinesterase inhibitors | Increased acetylcholine causes bronchoconstriction via muscarinic receptors | Used in Alzheimer disease (donepezil, rivastigmine) and myasthenia gravis; can cause bronchospasm and increased secretions | Use with caution in patients with asthma or chronic obstructive pulmonary disease; consider alternative dementia medications |
| Adenosine | Direct bronchoconstrictor effect via A1 receptors; also causes mast cell degranulation | Used for supraventricular tachycardia and in cardiac stress testing; can cause severe bronchospasm | Contraindicated in asthma; use alternative stress agents (dobutamine) for cardiac testing in asthmatics |
| Contrast media | Direct histamine release (anaphylactoid) or true immunoglobulin E-mediated anaphylaxis | Ranges from mild urticaria to severe bronchospasm and anaphylaxis; higher risk with ionic contrast | Use non-ionic low-osmolar contrast; premedication with corticosteroids and antihistamines for high-risk patients |
| Antibiotics (penicillins, cephalosporins, sulfonamides) | Immunoglobulin E-mediated type 1 hypersensitivity | Can range from isolated bronchospasm to full anaphylaxis; occurs within minutes to hours of exposure | Avoid offending agent and cross-reactive antibiotics; epinephrine for anaphylaxis |
| Inhaled medications (paradoxical bronchospasm) | Reaction to propellants, preservatives (benzalkonium chloride), or cold aerosol | Bronchospasm immediately after using inhaler; more common with nebulized medications | Switch to different inhaler device or formulation; use preservative-free nebulizer solutions |
Age-Based Differential Considerations
| Age Group | Most Likely Causes | Special Considerations |
|---|---|---|
| Young adults (18-40 years) | Asthma (most common), viral infections, vocal cord dysfunction, anxiety-related dyspnea | New-onset asthma can occur at any age; occupational exposures increasingly relevant |
| Middle-aged adults (40-65 years) | Asthma, early chronic obstructive pulmonary disease, asthma-chronic obstructive pulmonary disease overlap, gastroesophageal reflux disease | Smoking history becomes critical; consider early chronic obstructive pulmonary disease; new monophonic wheeze warrants malignancy workup |
| Older adults (greater than 65 years) | Chronic obstructive pulmonary disease, heart failure, asthma, endobronchial tumors | Cardiac asthma often missed; polypharmacy increases drug-induced causes; malignancy risk higher; multiple comorbidities common |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Episodic wheeze with nocturnal worsening and atopy | Asthma | Spirometry with bronchodilator reversibility testing |
| Progressive dyspnea in smoker with greater than 10 pack-years | Chronic obstructive pulmonary disease | Spirometry; expect fixed obstruction with FEV1/FVC less than 0.7 |
| Orthopnea with bilateral leg edema | Heart failure | Brain natriuretic peptide, echocardiogram, chest radiograph |
| Sudden onset after eating with urticaria | Anaphylaxis | Immediate epinephrine; stabilize airway |
| Unilateral wheeze with sudden onset and choking history | Foreign body aspiration | Chest radiograph (inspiratory and expiratory); bronchoscopy |
| Monophonic wheeze in smoker over age 40 | Endobronchial malignancy | Chest computed tomography; bronchoscopy |
| Inspiratory stridor with throat tightness and anxiety | Vocal cord dysfunction | Laryngoscopy during symptoms; flattened inspiratory loop on spirometry |
| Wheeze worse after meals and when supine | Gastroesophageal reflux disease | Empiric proton pump inhibitor trial; consider pH monitoring |
| Wheeze improving on weekends and holidays | Occupational asthma | Serial peak flow monitoring at work and away; specific challenge testing |
| Chronic productive cough with recurrent infections | Bronchiectasis | High-resolution chest computed tomography |
| New wheeze after starting beta-blocker or timolol eye drops | Drug-induced bronchospasm | Discontinue offending agent; reassess in 1-2 weeks |
6. Diagnostic Investigations
A stepwise, cost-effective approach guided by clinical suspicion
Baseline Investigations for All Patients with Chronic Wheezing
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Spirometry with bronchodilator reversibility | Confirm and characterize airway obstruction; assess reversibility | FEV1/FVC less than 0.7 confirms obstruction; increase in FEV1 greater than 12% AND greater than 200 mL post-bronchodilator suggests asthma | Essential first-line test; ensure patient withholds bronchodilators before test (short-acting 4-6 hours, long-acting 12-24 hours) |
| Chest radiograph (posteroanterior and lateral) | Exclude parenchymal disease, masses, cardiac enlargement, effusions | Hyperinflation (chronic obstructive pulmonary disease), cardiomegaly (heart failure), focal lesion (tumor), pneumothorax | Often normal in asthma; does not exclude diagnosis; useful to rule out alternative causes |
| Peak expiratory flow monitoring | Assess variability and severity; monitor response to treatment | Diurnal variation greater than 10% suggests asthma; less than 50% of predicted indicates severe obstruction | Useful for home monitoring; have patient record morning and evening values for 2 weeks |
| Complete blood count | Identify eosinophilia, anemia, polycythemia, infection | Eosinophilia greater than 300 cells per microliter supports allergic or eosinophilic asthma; polycythemia suggests chronic hypoxia | Eosinophil count guides biologic therapy eligibility in severe asthma |
| Oxygen saturation (pulse oximetry) | Assess oxygenation | Less than 92% warrants further evaluation; less than 90% requires supplemental oxygen | May be normal in early or mild disease; can be falsely normal in severe asthma due to hyperventilation |
Targeted Investigations by Suspected Etiology
If Suspecting Asthma
First-Line Tests
- Spirometry with bronchodilator reversibility: FEV1 increase greater than 12% AND greater than 200 mL is diagnostic
- Peak flow variability: Greater than 10% diurnal variation over 2 weeks supports diagnosis
- Fractional exhaled nitric oxide (FeNO): Greater than 50 parts per billion in adults strongly supports eosinophilic asthma; 25-50 parts per billion is intermediate
Second-Line Tests
- Bronchial challenge testing (methacholine or mannitol): If spirometry is normal but asthma suspected; PC20 less than 4 mg/mL is positive
- Allergy testing (skin prick or specific immunoglobulin E): Identifies triggers; guides allergen avoidance
- Total serum immunoglobulin E: Elevated in allergic asthma; required for omalizumab eligibility
If Suspecting Chronic Obstructive Pulmonary Disease
First-Line Tests
- Post-bronchodilator spirometry: FEV1/FVC less than 0.7 confirms diagnosis; FEV1 percent predicted determines severity (GOLD staging)
- Chest radiograph: Hyperinflation, flattened diaphragms, bullae; excludes other pathology
- Alpha-1 antitrypsin level: Test all patients with chronic obstructive pulmonary disease, especially if young onset (less than 45 years) or minimal smoking history
Second-Line Tests
- Chest computed tomography: If considering surgical options, suspecting bronchiectasis, or evaluating for malignancy
- Arterial blood gas: Assess for hypercapnia in severe disease (FEV1 less than 50% predicted)
- 6-minute walk test: Functional assessment; distance less than 350 meters indicates significant impairment
- Echocardiogram: If suspecting pulmonary hypertension or cor pulmonale
If Suspecting Heart Failure
First-Line Tests
- Brain natriuretic peptide (BNP) or N-terminal pro-BNP: BNP greater than 100 pg/mL or NT-proBNP greater than 300 pg/mL suggests heart failure; useful to distinguish cardiac from pulmonary cause of wheezing
- Electrocardiogram: May show left ventricular hypertrophy, ischemic changes, arrhythmia, or left bundle branch block
- Chest radiograph: Cardiomegaly, pulmonary venous congestion, Kerley B lines, pleural effusions
Second-Line Tests
- Transthoracic echocardiogram: Assess left ventricular ejection fraction, diastolic function, valvular disease, pulmonary artery pressure
- Renal function and electrolytes: Baseline before diuretic therapy; assess for cardiorenal syndrome
- Thyroid function: Both hyperthyroidism and hypothyroidism can cause or exacerbate heart failure
If Suspecting Vocal Cord Dysfunction
Diagnostic Tests
- Laryngoscopy during symptoms: Gold standard; shows paradoxical vocal cord adduction during inspiration
- Spirometry flow-volume loop: Flattening or truncation of the inspiratory limb; variable extrathoracic obstruction pattern
Supporting Evidence
- Normal spirometry between episodes: Unlike asthma, baseline lung function is typically normal
- Negative bronchial challenge: Helps exclude concomitant asthma
- Poor bronchodilator response: Does not improve with beta-agonists
If Suspecting Endobronchial Lesion or Malignancy
First-Line Tests
- Chest computed tomography with contrast: Identifies mass, lymphadenopathy, stenosis; evaluate mediastinum
- Sputum cytology: May identify malignant cells; low sensitivity but useful if positive
Definitive Tests
- Bronchoscopy with biopsy: Direct visualization and tissue diagnosis; can remove foreign body
- Positron emission tomography-computed tomography: Staging if malignancy confirmed
- Pulmonary function tests: Flow-volume loop may show fixed or variable obstruction pattern
Special Investigations
| Test | When to Order | What It Shows | Interpretation |
|---|---|---|---|
| High-resolution chest computed tomography | Suspected bronchiectasis, interstitial lung disease, or when chest radiograph is non-diagnostic | Airway wall thickening, bronchiectasis, air trapping (expiratory images), interstitial changes | Essential for bronchiectasis diagnosis; “signet ring sign” is pathognomonic |
| Methacholine challenge test | Normal spirometry but asthma clinically suspected; need to confirm or exclude diagnosis | Airway hyperresponsiveness | PC20 less than 4 mg/mL is positive; highly sensitive (negative test essentially rules out asthma) |
| Fractional exhaled nitric oxide (FeNO) | Assessing eosinophilic airway inflammation; monitoring response to corticosteroids; predicting steroid responsiveness | Marker of eosinophilic airway inflammation | Greater than 50 ppb: high probability of eosinophilic inflammation; less than 25 ppb: eosinophilic inflammation unlikely |
| Induced sputum analysis | Characterizing airway inflammation phenotype; guiding therapy in difficult asthma | Eosinophil and neutrophil counts | Eosinophils greater than 3%: eosinophilic asthma (steroid responsive); neutrophils greater than 61%: neutrophilic asthma |
| 24-hour esophageal pH monitoring | Suspected gastroesophageal reflux disease-associated wheeze; failed empiric proton pump inhibitor trial | Acid exposure time, reflux-symptom correlation | DeMeester score greater than 14.7 is abnormal; correlate reflux episodes with respiratory symptoms |
| Aspergillus serology and specific immunoglobulin E | Poorly controlled asthma with central bronchiectasis, elevated total immunoglobulin E | Sensitization to Aspergillus | Elevated specific immunoglobulin E to Aspergillus plus total immunoglobulin E greater than 1000 IU/mL suggests allergic bronchopulmonary aspergillosis |
Empiric Treatment Trials as Diagnostic Tools
Sequential Empiric Therapy Approach
When objective testing is inconclusive or unavailable, empiric treatment trials can serve as diagnostic tools. A positive response supports the suspected diagnosis. Use one trial at a time for adequate duration before concluding it was ineffective.
- Inhaled corticosteroid plus short-acting beta-agonist trial (4-8 weeks): Response supports asthma diagnosis; if FeNO is elevated, response is even more likely
- Proton pump inhibitor trial (8-12 weeks): High-dose twice-daily dosing; response suggests gastroesophageal reflux disease-associated bronchospasm
- Discontinuation of beta-blocker or angiotensin-converting enzyme inhibitor (2-4 weeks): Resolution or improvement supports drug-induced cause
- Intranasal corticosteroid plus antihistamine trial (2-4 weeks): Improvement suggests upper airway contribution (post-nasal drip, allergic rhinitis)
- Diuretic trial: Improvement in wheeze with diuresis supports cardiac asthma; monitor brain natriuretic peptide
Stepwise Investigation Approach
Recommended Sequence for Chronic Wheezing Workup:
- All patients: Spirometry with bronchodilator reversibility, chest radiograph, peak flow diary, complete blood count with differential
- If spirometry shows reversible obstruction: Diagnosis of asthma confirmed; consider allergy testing and FeNO to guide therapy
- If spirometry shows fixed obstruction: Diagnosis of chronic obstructive pulmonary disease likely; check alpha-1 antitrypsin
- If spirometry is normal but asthma suspected: Bronchial challenge testing (methacholine) or repeat spirometry when symptomatic
- If cardiac cause suspected: Brain natriuretic peptide, electrocardiogram, echocardiogram
- If inspiratory stridor or throat symptoms: Laryngoscopy during symptoms
- If focal wheeze or hemoptysis in smoker: Chest computed tomography, bronchoscopy
- If initial workup non-diagnostic: Consider empiric treatment trials, high-resolution computed tomography, specialized testing
Urgent Investigations in Acute Severe Wheezing
In patients with acute severe respiratory distress, prioritize stabilization over extensive investigation. Essential immediate tests include:
- Pulse oximetry and arterial blood gas: Assess oxygenation and ventilation; rising PaCO2 indicates fatigue and impending failure
- Peak expiratory flow: Less than 25% predicted indicates life-threatening attack
- Chest radiograph: Exclude pneumothorax, pneumonia
- Electrocardiogram: Exclude cardiac cause; identify arrhythmia
- Basic metabolic panel: Potassium (beta-agonist effect), assess for acidosis
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Silent chest with respiratory distress, altered consciousness, or cyanosis | LIFE-THREATENING | Call for help, prepare for intubation, continuous nebulized bronchodilators, intravenous corticosteroids, epinephrine if anaphylaxis suspected |
| Oxygen saturation less than 90%, unable to speak in sentences, peak flow less than 33% predicted | SEVERE | High-flow oxygen, back-to-back nebulized bronchodilators, systemic corticosteroids, consider intravenous magnesium sulfate, monitor closely for deterioration |
| Sudden onset with urticaria, facial swelling, or known allergen exposure | EMERGENT | Intramuscular epinephrine immediately (0.3-0.5 mg of 1:1000), secure airway, establish intravenous access, antihistamines, corticosteroids |
| Unilateral wheeze with sudden onset after eating or playing with small objects | EMERGENT | Keep patient calm, avoid blind finger sweeps, urgent bronchoscopy for removal; Heimlich maneuver only if complete obstruction |
| Moderate wheeze, oxygen saturation 90-94%, speaks in phrases, peak flow 33-50% predicted | URGENT | Supplemental oxygen to maintain saturation greater than 94%, nebulized bronchodilators every 20 minutes for 3 doses, oral or intravenous corticosteroids, reassess response |
| Wheeze with orthopnea, elevated jugular venous pressure, peripheral edema | URGENT | Sit patient upright, supplemental oxygen, intravenous diuretics (furosemide 40-80 mg), electrocardiogram, consider non-invasive ventilation if severe |
| Mild wheeze, oxygen saturation greater than 94%, speaks in sentences, peak flow greater than 50% predicted | ROUTINE | Inhaled short-acting beta-agonist via metered-dose inhaler with spacer, reassess in 20 minutes, oral corticosteroids if incomplete response, outpatient follow-up |
| Chronic stable wheeze with no acute distress | NON-URGENT | Systematic outpatient workup with spirometry, review medications and inhaler technique, optimize maintenance therapy |
Step 2: Classify by Duration and Context
Acute (Less than 2 weeks)
First consideration: Is this a life-threatening emergency?
Common causes: Asthma exacerbation, viral infection, anaphylaxis
Proceed to: Algorithm A
Subacute (2 to 8 weeks)
First consideration: Post-infectious versus new diagnosis
Common causes: Post-viral bronchial hyperreactivity, undiagnosed asthma
Proceed to: Algorithm B
Chronic (Greater than 8 weeks)
First consideration: Systematic workup required
Common causes: Asthma, chronic obstructive pulmonary disease, heart failure
Proceed to: Algorithm C
Step 3: Follow the Appropriate Algorithm
Algorithm A: Acute Wheezing
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Known asthmatic with trigger exposure, episodic pattern, responds to bronchodilator | Acute asthma exacerbation | Bronchodilators, systemic corticosteroids, assess severity and disposition, review maintenance therapy |
| Preceding coryza, low-grade fever, diffuse wheeze, otherwise well | Viral respiratory infection with reactive airways | Supportive care, bronchodilators as needed, reassurance; consider short course of inhaled corticosteroids if recurrent |
| Smoker with chronic cough, increased sputum purulence, worsening dyspnea | Acute exacerbation of chronic obstructive pulmonary disease | Bronchodilators, systemic corticosteroids, antibiotics if purulent sputum, oxygen to target 88-92% |
| Rapid onset after eating, medication, or sting; urticaria, angioedema present | Anaphylaxis | Intramuscular epinephrine immediately, secure airway, intravenous fluids, observe for biphasic reaction |
| Orthopnea, paroxysmal nocturnal dyspnea, leg edema, crackles on auscultation | Acute heart failure (cardiac asthma) | Sit upright, oxygen, intravenous diuretics, consider non-invasive ventilation, identify precipitant (ischemia, arrhythmia) |
| Sudden unilateral wheeze after eating or choking episode | Foreign body aspiration | Chest radiograph (inspiratory and expiratory), urgent bronchoscopy for localization and removal |
| Sudden dyspnea, pleuritic chest pain, unilateral leg swelling, risk factors present | Pulmonary embolism | Computed tomography pulmonary angiogram, anticoagulation if confirmed, hemodynamic support if massive |
Algorithm B: Subacute Wheezing (2 to 8 Weeks)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Wheeze persisting after respiratory infection, no prior asthma history | Post-infectious bronchial hyperreactivity | Trial of inhaled corticosteroid plus short-acting beta-agonist for 4-6 weeks; if persists, spirometry |
| Recurrent wheeze with triggers, atopic history, nocturnal symptoms | New-onset asthma (undiagnosed) | Spirometry with bronchodilator reversibility, initiate controller therapy, allergy evaluation |
| Paroxysmal cough with whooping, vomiting after coughing fits | Pertussis | Nasopharyngeal polymerase chain reaction for Bordetella pertussis, macrolide antibiotic (azithromycin), isolate until 5 days of treatment |
| Wheeze started after beginning new medication (beta-blocker, nonsteroidal anti-inflammatory drug) | Drug-induced bronchospasm | Discontinue offending agent, reassess in 2-4 weeks; symptoms should improve |
| Wheeze with productive cough, focal crackles, fever history | Resolving pneumonia with bronchial hyperreactivity | Ensure antibiotic course completed, repeat chest radiograph to confirm resolution, bronchodilators as needed |
Algorithm C: Chronic Wheezing (Greater than 8 Weeks)
| Clinical Scenario | Most Likely Diagnosis | Action |
|---|---|---|
| Variable wheeze, nocturnal symptoms, triggers identified, atopy, reversible obstruction on spirometry | Asthma | Confirm with spirometry, initiate inhaled corticosteroid, develop action plan, identify and avoid triggers, assess control regularly |
| Progressive dyspnea, smoking history greater than 10 pack-years, fixed obstruction on spirometry | Chronic obstructive pulmonary disease | Confirm with post-bronchodilator spirometry, smoking cessation (most important), long-acting bronchodilators, pulmonary rehabilitation |
| Features of both asthma and chronic obstructive pulmonary disease, significant smoking plus atopy | Asthma-chronic obstructive pulmonary disease overlap | Treat with inhaled corticosteroid plus long-acting beta-agonist plus long-acting muscarinic antagonist, smoking cessation essential |
| Wheeze with orthopnea, elevated brain natriuretic peptide, cardiac history | Heart failure (cardiac asthma) | Echocardiogram, optimize heart failure therapy (diuretics, angiotensin-converting enzyme inhibitors, beta-blockers once euvolemic), cardiology referral |
| Inspiratory stridor, throat tightness, anxiety triggers, normal spirometry between episodes | Vocal cord dysfunction | Laryngoscopy during symptoms to confirm, speech therapy for laryngeal control techniques, treat comorbid anxiety |
| Monophonic wheeze, hemoptysis, weight loss, smoker over age 40 | Endobronchial malignancy | Urgent chest computed tomography, bronchoscopy with biopsy, staging workup, oncology referral |
| Chronic productive cough, recurrent infections, bronchiectasis on imaging | Bronchiectasis | High-resolution computed tomography to confirm, sputum culture, airway clearance techniques, treat exacerbations promptly |
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient not responding to bronchodilators in acute setting | Reassess diagnosis—consider anaphylaxis, cardiac asthma, foreign body, vocal cord dysfunction, or tension pneumothorax | Treat underlying cause; if true refractory asthma, add intravenous magnesium sulfate, consider non-invasive ventilation, prepare for intubation |
| Patient on beta-blocker presenting with new wheezing | Discontinue beta-blocker if possible (including eye drops), provide bronchodilator | Reassess in 1-2 weeks; if asthmatic, avoid all beta-blockers; if essential for cardiac indication, use cardioselective agent with extreme caution |
| Spirometry is normal but patient describes classic asthma symptoms | Order peak flow diary for 2 weeks to capture variability | If variability greater than 10%, diagnose asthma; if normal, proceed to methacholine challenge test |
| Patient has both asthma symptoms and significant smoking history | Perform spirometry with bronchodilator; check for eosinophilia and immunoglobulin E | Treat as asthma-chronic obstructive pulmonary disease overlap with inhaled corticosteroid-containing regimen; smoking cessation is paramount |
| Elderly patient with new wheeze and leg swelling | Check brain natriuretic peptide, electrocardiogram, chest radiograph | If cardiac cause confirmed, treat heart failure; avoid attributing to “late-onset asthma” without excluding cardiac disease |
| Patient describes throat tightness more than chest tightness | Consider vocal cord dysfunction; examine flow-volume loop for inspiratory flattening | Arrange laryngoscopy during symptoms; refer to speech therapy if confirmed |
| Wheeze is localized to one area of the chest | Obtain chest radiograph and computed tomography | Bronchoscopy to evaluate for foreign body, tumor, or mucus plug; biopsy any visible lesion |
| Asthma well-controlled but patient using excessive reliever medication | Review inhaler technique and adherence to controller medication | Step up controller therapy, consider adding long-acting muscarinic antagonist or biologic if severe; address triggers |
Assessing Asthma Control in Chronic Management
| Feature | Well Controlled | Partly Controlled | Uncontrolled |
|---|---|---|---|
| Daytime symptoms | 2 or fewer times per week | More than 2 times per week | 3 or more features of partly controlled asthma present |
| Night waking due to asthma | None | Any | |
| Reliever use for symptoms | 2 or fewer times per week | More than 2 times per week | |
| Activity limitation | None | Any | |
| Lung function (FEV1 or peak flow) | Normal or greater than 80% predicted | Less than 80% predicted | Less than 80% predicted |
| Exacerbations | None | 1 or more per year | 1 in any week |
Troubleshooting Refractory Wheezing
Ask These Questions When Wheezing Persists Despite Treatment
- Is the diagnosis correct? Re-evaluate—could this be vocal cord dysfunction, cardiac asthma, or endobronchial lesion?
- Is the patient using medications correctly? Check inhaler technique at every visit; spacer use; adherence to controller therapy
- Are there ongoing trigger exposures? Occupational, environmental, allergens, irritants, pets
- Are comorbidities being addressed? Gastroesophageal reflux disease, rhinosinusitis, obesity, obstructive sleep apnea, anxiety
- Is the patient still smoking? Smoking reduces corticosteroid efficacy and accelerates decline
- Are there drug interactions or iatrogenic causes? Beta-blockers, nonsteroidal anti-inflammatory drugs, angiotensin-converting enzyme inhibitors
- Could there be multiple overlapping conditions? Asthma plus heart failure, asthma plus chronic obstructive pulmonary disease, asthma plus vocal cord dysfunction
- Has the treatment duration been adequate? Inhaled corticosteroids require 2-4 weeks for full effect; proton pump inhibitors require 8-12 weeks
When to Refer to a Specialist
| Refer To | Indications |
|---|---|
| Pulmonologist | Uncertain diagnosis despite initial workup; severe or difficult-to-control asthma requiring step 4-5 therapy; consideration for biologics; suspected interstitial lung disease or bronchiectasis; need for bronchoscopy |
| Allergist/Immunologist | Suspected allergic asthma requiring allergy testing; consideration for immunotherapy; recurrent anaphylaxis; suspected allergic bronchopulmonary aspergillosis |
| Cardiologist | Suspected cardiac asthma; heart failure with preserved ejection fraction; valvular disease; pulmonary hypertension |
| Otolaryngologist | Suspected vocal cord dysfunction requiring laryngoscopy; upper airway obstruction; chronic rhinosinusitis with nasal polyps |
| Gastroenterologist | Suspected gastroesophageal reflux disease not responding to empiric therapy; need for pH monitoring or endoscopy |
| Thoracic surgeon or Interventional pulmonologist | Endobronchial tumor requiring resection; tracheal stenosis; foreign body that cannot be removed bronchoscopically |
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
All that wheezes is not asthma: Always consider heart failure, vocal cord dysfunction, foreign body, and endobronchial tumors in the differential. A monophonic wheeze in a smoker over age 40 demands imaging to exclude malignancy.
The silent chest is an ominous sign: Absence of wheezing in a patient with severe respiratory distress indicates critically reduced airflow. This patient needs immediate escalation of care, not reassurance.
Check the medication list for beta-blockers—including eye drops: Timolol ophthalmic drops for glaucoma are a frequently overlooked cause of severe bronchospasm in asthmatics. Always ask specifically about eye medications.
Cardiac asthma is real and commonly missed: Elderly patients with new-onset wheezing and orthopnea may have heart failure, not asthma. Check brain natriuretic peptide before committing to an asthma diagnosis in this population.
Spirometry is essential, not optional: Objective confirmation of obstruction and reversibility is required for accurate diagnosis. Clinical assessment alone is insufficient and leads to both over- and under-diagnosis.
Inhaler technique matters more than the medication: Up to 90% of patients use inhalers incorrectly. Always demonstrate and verify technique before escalating therapy. A spacer significantly improves metered-dose inhaler delivery.
Look in the ear: Arnold’s nerve reflex means that cerumen impaction or ear pathology can trigger chronic cough and wheeze. A quick otoscopic examination may reveal an unexpected cause.
Vocal cord dysfunction often coexists with asthma: Up to 40% of patients with difficult-to-control asthma have concurrent vocal cord dysfunction. Suspect this when symptoms are predominantly inspiratory or localized to the throat.
Critical Pitfalls to Avoid
Dismissing wheezing because the examination is normal: Intermittent asthma frequently presents with normal examination between episodes. Rely on history, peak flow variability, and spirometry with bronchial challenge if needed.
Treating all wheezing with bronchodilators: Bronchodilators will not help cardiac asthma, vocal cord dysfunction, or fixed upper airway obstruction. Correct diagnosis guides effective treatment.
Forgetting anaphylaxis in rapidly progressive wheezing: Wheezing with urticaria, angioedema, or hypotension requires epinephrine immediately—not just bronchodilators. Delayed epinephrine administration increases mortality.
Attributing new wheeze in a smoker to chronic obstructive pulmonary disease without imaging: Lung cancer can present with localized wheeze. All smokers with new respiratory symptoms need chest imaging, not just a prescription for inhalers.
Over-relying on short-acting bronchodilators in asthma: Regular reliever use without adequate controller therapy leads to increased exacerbations and mortality. Patients using more than one short-acting beta-agonist canister per month are at risk.
Missing aspirin-exacerbated respiratory disease: Patients with asthma, nasal polyps, and aspirin or nonsteroidal anti-inflammatory drug sensitivity have a distinct phenotype requiring strict avoidance and specialized management.
Failing to consider multiple coexisting diagnoses: Asthma plus gastroesophageal reflux disease, chronic obstructive pulmonary disease plus heart failure, or asthma plus vocal cord dysfunction may all be present simultaneously. Treat all contributing conditions.
Inadequate follow-up after acute exacerbation: Patients discharged after asthma exacerbation need follow-up within 1-2 weeks to assess recovery, review triggers, optimize controller therapy, and provide an asthma action plan.
Key Takeaways
- Wheezing indicates airway narrowing from bronchospasm, mucosal edema, mucus, or structural obstruction—identify the mechanism to guide treatment
- Classify wheezing by duration (acute, subacute, chronic), character (monophonic versus polyphonic), and phase (inspiratory versus expiratory) to narrow the differential
- Asthma, chronic obstructive pulmonary disease, and heart failure account for the majority of chronic wheezing in adults, but always consider alternative diagnoses
- Red flags requiring urgent evaluation include: silent chest, inability to speak, cyanosis, hypotension, sudden onset with choking, and hemoptysis with weight loss
- Spirometry with bronchodilator reversibility is the essential first-line investigation for chronic wheezing; normal spirometry does not exclude asthma if bronchial challenge is positive
- Always review the medication list for drugs that cause or exacerbate wheezing: beta-blockers (including ophthalmic), nonsteroidal anti-inflammatory drugs, angiotensin-converting enzyme inhibitors
- A monophonic wheeze suggests focal obstruction—foreign body, tumor, or extrinsic compression—and warrants imaging and possible bronchoscopy
- Cardiac asthma is underdiagnosed in the elderly; elevated brain natriuretic peptide and response to diuretics confirm the diagnosis
- Inhaler technique is frequently poor; demonstration and verification at every visit is more valuable than escalating medications
- Empiric treatment trials (inhaled corticosteroids, proton pump inhibitors, medication discontinuation) can serve as diagnostic tools when investigations are inconclusive
- Vocal cord dysfunction can mimic asthma and often coexists with it; suspect when symptoms are inspiratory, throat-centered, and bronchodilator-unresponsive
- The goal in asthma management is control—minimal symptoms, no nocturnal waking, no activity limitation, and no exacerbations—not just absence of wheeze
Quick Reference Algorithm
Systematic Approach to the Patient with Wheezing:
- Assess urgency: Is this life-threatening? Look for silent chest, inability to speak, cyanosis, altered mental status, or anaphylaxis features. Stabilize before investigating.
- Characterize the wheeze: Acute or chronic? Monophonic or polyphonic? Inspiratory or expiratory? Episodic or persistent?
- Take a focused history: Use the WHEEZE mnemonic—When/triggers, How it sounds, Episodes or everyday, Extra symptoms, Zoning in on risk factors, Effect on life and existing treatments
- Examine systematically: Vital signs including oxygen saturation, upper airway (stridor?), chest (wheeze character, symmetry, air entry), and cardiovascular system (jugular venous pressure, edema, gallops)
- Order baseline investigations: Spirometry with bronchodilator reversibility, chest radiograph, peak flow monitoring, complete blood count
- Consider the “Big Three” first: Asthma, chronic obstructive pulmonary disease, and heart failure account for most chronic wheezing; pursue targeted investigations based on clinical suspicion
- Review medications: Beta-blockers, nonsteroidal anti-inflammatory drugs, angiotensin-converting enzyme inhibitors can all cause or worsen wheezing
- Initiate appropriate treatment: Match therapy to diagnosis; verify inhaler technique; address comorbidities and triggers
- Reassess and adjust: Monitor control, step up or down therapy as indicated, maintain vigilance for alternative diagnoses if response is poor
- Refer when indicated: Uncertain diagnosis, severe disease, need for advanced testing or specialist therapies